Literature DB >> 9888254

Cyclic GMP-independent mechanisms of nitric oxide-induced vasodilation.

C Goud1, A DiPiero, W E Lockette, R C Webb, J R Charpie.   

Abstract

1. The aim of the present study was to test in vitro if NO acts through a cyclic GMP-independent mechanism to activate Ca2+-dependent potassium channels (K+(Ca)), leading to membrane hyperpolarization and vasodilation in rat tail artery. 2. Acetylcholine and sodium nitroprusside stimulated a significant increase in cyclic GMP (190+/-23 and 180+/-15 pmol/g, respectively) compared with agonist-free conditions (132+/-15 and 130+/-15 pmol/g, respectively); these agonist-mediated increases in cyclic GMP were completely abolished by treatment with the guanylate cyclase inhibitor methylene blue (122+/-10 and 60+/-8 pmol/g, respectively). 3. In contrast, relaxation to acetylcholine (10(-7) mol/l; 61+/-3%) and sodium nitroprusside (10(-8) mol/l; 97+/-1%) were significantly, but not completely, attenuated by methylene blue (30+/-5 and 79+/-3%, respectively); maximum relaxation to sodium nitroprusside (10(-7) mol/l) was unaffected by methylene blue. 4. Depolarization-induced contraction of vessels with KCl inhibited relaxation to both acetylcholine (10(-7) mol/l; 18+/-4%) and sodium nitroprusside (10(-8) mol/l; 57+/-7%). Furthermore, the specific K+(Ca) antagonist charybdotoxin significantly inhibited relaxation to sodium nitroprusside (10(-8) mol/l; 52+/-7%). 5. An additive inhibitory effect on relaxation to sodium nitroprusside (10(-8) mol/l) was observed with a combination of methylene blue and KCl (26+/-6%) or charybdotoxin (34+/-3%). 6. These data suggest that NO stimulates membrane hyperpolarization via K+(Ca) activation, in addition to guanylate cyclase, to cause relaxation in rat tail artery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888254     DOI: 10.1016/s0306-3623(98)00059-7

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 2.  Regulation of K-Cl cotransport: from function to genes.

Authors:  N C Adragna; M Di Fulvio; P K Lauf
Journal:  J Membr Biol       Date:  2004-10-01       Impact factor: 1.843

3.  The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.

Authors:  Terry C Major; Hitesh Handa; Elizabeth J Brisbois; Melissa M Reynolds; Gail M Annich; Mark E Meyerhoff; Robert H Bartlett
Journal:  Biomaterials       Date:  2013-07-29       Impact factor: 12.479

Review 4.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

5.  Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.

Authors:  Renu R Raj; Sathya Subramani
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.